In the future, the association of IGF-1, the IGF system and the 19-19 repeat P1 promoter IGF-1 gene and the clinical outcome of cervical cancer patients in post-treatment samples may add significance in disease mapping as a prognostic marker. The gene discussed is IGF1; the disease is cervical carcinoma.